Laboratory of Virology and Infectious Disease
- Virus-Host Interactions
Cell, Volume 146, Issue 2, 22 July 2011, Pages 183,185, ISSN 0092-8674, 10.1016/j.cell.2011.07.002.
- Hepatitis C mouse model a major milestone. Development paves the way for testing potential vaccines.
- Scientists create humanized mouse model for hepatitis C
- TWiV 137: Look what the dog dragged in (June 12, 2011)
- Homo musculus: Researchers Create a "Humanized" Mouse for Liver Disease Studies (2010)
- Dissecting the Molecular Virology of Hepatitis C and Identifying New Targets for Therapies: 20 years of HCV Research at the Rockefeller University Hospital Centennial (2010)
- Lab-grown Liver Cells Provide Model for Hepatitis C Infection (2010)
- HCV's mighty mouse (2011)
- Research technique: The murine candidate (2011)
- Researchers Advance Study of Hepatitis C with New Model (2011)
- Profile of Charles M. Rice in PNAS (2011)
- Hepatitis C mouse model a major milestone. Development paves the way for testing potential vaccines. (2011)
- Scientists create humanized mouse model for hepatitis C (2011)
- TWiV 137: Look what the dog dragged in (June 12, 2011)
- Homo musculus: Researchers Create a "Humanized" Mouse for Liver Disease Studies (2010)
- Dissecting the Molecular Virology of Hepatitis C and Identifying New Targets for Therapies: 20 years of HCV Research at the Rockefeller University Hospital Centennial (2010)
- Lab-grown Liver Cells Provide Model for Hepatitis C Infection (2010)
- Researchers modify yellow fever vaccine to fight malaria (2010)
- BBC News: Hepatitis fight aided by liver cells advance (2010)
- Engineering a new way to study hepatitis C (2010)
- Scientists visualize how a vital hepatitis C virus protein moves along its nucleic acid substrate (2009)
- Multitasking may be Achilles heel for hepatitis C (2009)
- Rockefeller virologists and MIT tissue engineers receive $5.8 million NIH grant to study hepatitis (2009)
- Discovery could lead to a new animal model for hepatitis C (2009)
- By imaging live cells, researchers show how hepatitis C replicates (2008)
- New Theory Suggests How Hepatitis C May Cause Rare Immune Disease (2008)
- New Hepatitis C Advisory Council Draws Praise From Commissioner, Legislators, Advocates (2008)
- Hepatitis C Researcher to Receive Prize (2007)
- 2 Winning Drug Tests, One Expected and One a Surprise
- Ira M. Jacobson named "Physician of the Year" by the American Liver Foundation (2007)
- New Drugs, Dosing Highlight New Approaches to Hepatitis C (2007)
- Projects in Knowledge: Hepatitis C: From Scientific Foundations to New Vistas in Treatment (2007)
- Hepatitis C virus blocks 'superinfection' (2007)
- Key protein for hepatitis C virus entry identified (2007)
- Key protein for hepatitis C virus entry identified (2007)
- Trial Confirms Power of Hepatitis C Combo Therapy (2006)
- WIN-R Study Demonstrates Efficacy of Shorter PEG-INTRON and REBETOL Regimen in Hepatitis C Patients with Genotype 2 or 3 Virus (2006)
- Win-R Study: Ribavirin Weight-Base Dosing in High Weight Patients; Treatment Responses to PegIntron/RBV for Elderly Patients and by Patient Ethnicity (2006)
- Largest U.S. Hepatitis C Trial Provides Insight Into Optimizing Treatment for Patients (2006)
- New Data From Largest U.S. Hepatitis C Trial Provide Insights Into Optimizing Treatment For Patient Populations (2006)
- Projects in Knowledge: Revolutionizing the Way We Treat HCV: STAT-C (2006)
- Researchers show laboratory hepatitis C strain is also infectious in animal models (2006)
- Largest Hepatitis C Trial in U.S. Patients Shows Weight-Based REBETOL in Combination with PEG-INTRON Increases Sustained Response, Lowers Relapse (2005)
- Does Weight-based Ribavirin Dosing Increase Sustained Viral Response in Patients with Chronic Hepatitis C? Final Results of the WIN-R Study (2005)
- Building a better vaccine (2005)
- How does your virus grow? (2005)
- Researchers create infectious hepatitis C virus in a test tube (2005)
- Science Briefs - Role for dendritic cells in HCV (2004)
- Study shows weight-based REBETOL dosing in combination with PEG-INTRON significantly improves viral clearance in African-American patients with most-difficult-to-treat form of hepatitis C. (2004)
- Interview with Charles M. Rice, PhD (2004)
- Hepatitis C: Progress toward New Therapies (2004)
- Hepatitis C's time bomb ticks, Chicago Tribune December 1, 2003
- Researchers Identify Key to Genetic Replication in Hepatitis C Virus (2000)
- University and neighbors form joint HCV research center (2000)
- First Hepatitis-C Center in Northeast Region Established By Rockefeller University, New York-Presbyterian, and Weill Cornell (2000)
